UnicoCell Biomed Co., Ltd. (stock code: 6794), specializing in the development of allogeneic stem cells new drugs, held the Pre-IPO Investor Conference on 18th April 2024 at the Grand Hyatt Taipei on the TIB (Taiwan Innovation Board) of the TWSE (Taiwan Stock Exchange). Officials of the Taiwan Stock Exchange graces the event with their presence and invaluable guidance; as well as over 200 investors from various sectors attended. With an enthusiastic Q&A session, the conference culminated in a successful and fulfilling conclusion.
During the investor conference, two patients put on a dance show to claim that their regain of joy from dancing after autologous stem cell treatment under the RASMET (Regulation Governing the Application of Specific Medical Examination Technique and Medical Device) collaborating between UnicoCell and hospital. They regained the joy of dancing after receiving autologous stem cell therapy for knee osteoarthritis and heightened the level of excitement at the event by a live dance show. Additionally, a 108-year-old patient shared his experience after received compassionate use with UnicoCell's allogeneic stem cells. It was very impressive! During the event, Chairman I-Wen Tsai introduced the distinguished guests, followed by an inspiring speech delivered by Dr. Po-Huang Lee M.D., Ph.D., Professor Emeritus at National Taiwan University. Finally, Dr. Yi-Pei Hung, the CEO, presented the UnicoCell's latest developments and achievements. For more information, please refer to the following link
Contact: Terry Lee
Phone: 886-2-27922699
Mail: info@unicocell.com